Circulating immune checkpoints predict heart failure outcomes
Abstract Aims There are limited data examining the role of immune checkpoint (IC) ligands in the pathophysiology of heart failure (HF). Therefore, we explore this in three HF animal models and in three different human cohorts (healthy, stable, and worsening HF). Methods and results Transcriptomic an...
Autores principales: | Elles M. Screever, Laura I.E. Yousif, Javid J. Moslehi, Joe‐Elie Salem, Adriaan A. Voors, Herman H.W. Silljé, Rudolf A. deBoer, Wouter C. Meijers |
---|---|
Formato: | Artículo |
Lenguaje: | English |
Publicado: |
Wiley
2023-08-01
|
Colección: | ESC Heart Failure |
Materias: | |
Acceso en línea: | https://doi.org/10.1002/ehf2.14304 |
Ejemplares similares
-
Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study
por: Douglas B. Johnson, et al.
Publicado: (2019-05-01) -
Checkpoint Inhibition in Myeloma: Opportunities and Challenges
por: Federica Costa, et al.
Publicado: (2018-09-01) -
The role of immune checkpoints in cardiovascular disease
por: Laura I. Yousif, et al.
Publicado: (2022-10-01) -
Enhancing cancer care with improved checkpoint inhibitors
por: Vickram A S, et al.
Publicado: (2024-10-01) -
Checkmate with checkpoint inhibitors: New paradigm in immunotherapy
por: Ruby Dhar, et al.
Publicado: (2023-04-01)